GB Sciences, Inc. (GBLX) financial statements (2020 and earlier)

Company profile

Business Address 6450 CAMERON STREET #110A
LAS VEGAS, NV 89118
State of Incorp. DE
Fiscal Year End March 31
SIC 1311 - Crude Petroleum and Natural Gas (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
Q3
9/30/2019
Q2
6/30/2019
Q1
3/31/2019
Q4
12/31/2018
Q3
9/30/2018
Q2
6/30/2018
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments0000035
Cash and cash equivalents0000035
Receivables1000011
Inventory, net of allowances, customer advances and progress billings2232321
Inventory2232321
Prepaid expense  01112
Disposal group, including discontinued operation 1     
Other undisclosed current assets00     
Total current assets:3343569
Noncurrent Assets
Operating lease, right-of-use asset000 
Property, plant and equipment10102324232116
Long-term investments and receivables5      
Accounts and financing receivable, after allowance for credit loss5      
Intangible assets, net (including goodwill)2222221
Intangible assets, net (excluding goodwill)2222221
Deposits noncurrent assets0011111
Disposal group, including discontinued operation, noncurrent assets 14     
Other undisclosed noncurrent assets  00000
Total noncurrent assets:18262727262419
TOTAL ASSETS:21303030313028
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities3344411
Accounts payable2223200
Accrued liabilities0000000
Taxes payable11111  
Interest and dividends payable0000000
Debt5553111
Due to related parties0      
Disposal group, including discontinued operation 2     
Total current liabilities:9997522
Noncurrent Liabilities
Long-term debt and lease obligation4460666
Long-term debt, excluding current maturities 000000
Finance lease, liability446 
Capital lease obligations666
Operating lease, liability000 
Liabilities, other than long-term debt 2     
Disposal group, including discontinued operation, liabilities 2     
Other undisclosed noncurrent liabilities   6   
Total noncurrent liabilities:4666666
Total liabilities:131615131188
Stockholders' equity
Stockholders' equity attributable to parent8578101313
Common stock0000000
Additional paid in capital97959493908980
Accumulated deficit(89)(90)(87)(85)(80)(76)(66)
Stockholders' equity attributable to noncontrolling interest 999996
Total stockholders' equity:8141617192220
TOTAL LIABILITIES AND EQUITY:21303030313028

Income statement (P&L) ($ in millions)

12/31/2019
Q3
9/30/2019
Q2
6/30/2019
Q1
3/31/2019
Q4
12/31/2018
Q3
9/30/2018
Q2
6/30/2018
Q1
Revenues0111111
Cost of revenue(1)(2)(1)(2)(0)(0)(1)
Gross profit:(0)(1)0(1)001
Operating expenses(2)(1)(2)(4)(3)(5)(4)
Operating loss:(2)(2)(2)(5)(3)(4)(4)
Nonoperating income (expense)4(0)(1)(0)(1)(6)(2)
Investment income, nonoperating5      
Debt instrument, convertible, beneficial conversion feature 0     
Other nonoperating income (expense)(0)  (0)(0)(3)0
Interest and debt expense(0)(0)(1)(0)(0)(3)(2)
Income (loss) from continuing operations before equity method investments, income taxes:2(3)(3)(6)(4)(13)(7)
Other undisclosed income from continuing operations before income taxes00100  
Income (loss) from continuing operations before income taxes:2(2)(2)(5)(3)(13)(7)
Income tax expense (benefit) 0(0)0(1)  
Income (loss) from continuing operations:2(2)(3)(5)(4)(13)(7)
Loss from discontinued operations(1)(0)     
Income (loss) before gain (loss) on sale of properties:1(3)(3)(5)(4)(13)(7)
Other undisclosed net income     32
Net income (loss):1(3)(3)(5)(4)(10)(5)
Net income attributable to noncontrolling interest0000000
Net income (loss) attributable to parent:1(3)(2)(5)(4)(10)(5)
Other undisclosed net loss available to common stockholders, basic   (3)   
Net income (loss) available to common stockholders, basic:1(3)(2)(8)(4)(10)(5)
Interest on convertible debt0      
Dilutive securities, effect on basic earnings per share0      
Other undisclosed net loss available to common stockholders, diluted(0)      
Net income (loss) available to common stockholders, diluted:1(3)(2)(8)(4)(10)(5)

Comprehensive Income ($ in millions)

12/31/2019
Q3
9/30/2019
Q2
6/30/2019
Q1
3/31/2019
Q4
12/31/2018
Q3
9/30/2018
Q2
6/30/2018
Q1
Net income (loss):1(3)(3)(5)(4)(10)(5)
Comprehensive income (loss):1(3)(3)(5)(4)(10)(5)
Comprehensive income, net of tax, attributable to noncontrolling interest0000000
Comprehensive income (loss), net of tax, attributable to parent:1(3)(2)(5)(4)(10)(5)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: